Fisher & Paykel Healthcare Corporation Limited · NZX:FPH
Fisher & Paykel Healthcare — ASX CEO Connect conference (June 2023)
10 slides from Fisher & Paykel Healthcare's conference presentation, Jun 20, 2023
Slide 1: Fisher & Paykel Healthcare provides ASX CEO Connect presentation
News Release STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH) Fisher & Paykel Healthcare provides ASX CEO Connect presentation Auckland, New Zealand, 20 June 2023 - Fisher & Paykel Healthcare Corporation Limited attaches a copy of its presentation for the ASX’s CEO Connect webinar to be h
Slide 2: ASX CEO Connect conference – Fisher & Paykel Healthcare
For personal use only ASX 1 CEO Connect conference – Fisher & Paykel Healthcare
Slide 3: Fisher & Paykel Healthcare at a glance
Fisher & Paykel Healthcare at a glance Global leader in respiratory Global presence humidification devices For personal use only • Medical device manufacturer with leading positions Our people in respiratory care and obstructive sleep apnea are located in • >50 years’ experience in changing clinical
Slide 4: ~NZ$25+ billion and growing market opportunity
~NZ$25+ billion and growing market opportunity Total addressable market estimates HOSPITAL HOMECARE For personal use only ~150+ million patients ~100+ million patients Invasive Noninvasive Hospital Home Respiratory Obstructive Sleep Respiratory Support Anesthesia Support Apnea Ventilation Ventilatio
Slide 5: Our progress over the last five years
Our progress over the last five years FY2019 FY2023 Change Comment Countries with F&P people 38 53 39% • COVID-19 accelerated expansion For personal use only Total people 4,547 6,564 44% People in Manufacturing & Operations 2,680 3,975 48% • Peaked at 4,989 in FY22 People in R&D 581 846 46% • Accele
Slide 6: 10-year financial summary
10-year financial summary Revenue Net profit after tax For personal use only $2.0b $500m $1.5b $400m $300m $1.0b $200m $0.5b $100m $0.0b $0m FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 Hospital Revenue Homecare Revenue 5
Slide 7: Gross margin and operating margin targets
Gross margin and operating margin targets GROSS MARGIN OPERATING (EBIT) MARGIN For personal use only 70% 40% 60% 35% 30% 50% 25% 40% 20% 30% 15% 20% 10% 10% 5% 0% 0% FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 Long Term Gross Margin target Long
Slide 8: Our aspiration
Our aspiration OUR ASPIRATION: Sustainably For personal use only DOUBLING our constant currency revenue every 5-6 years. 7 The image above is an illustration of the company’s long-term growth aspirations. It is not a graph and should not be interpreted as being indicative of levels of revenue or pro
Slide 9: Questions
For personal use only 8 Questions
Slide 10: Thank you
For personal use only 9 Thank you
Fisher & Paykel Healthcare — ASX CEO Connect conference (June 2023) on 6ix